None ...

Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drugs in the class.

This is read by an automated voice. Please report any issues or inconsistencies here. A series of storms drenching California continued to cause problems across the Southland on Wednesday, triggering ...

A famous name will return to familiar territory. Collingwood superstar Nick Daicos will spend his resting minutes away from the midfield at full forward this season. He should know a thing or two ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

A former St. Louis city building inspector was indicted Wednesday on three counts of wire fraud for allegedly funneling city construction contracts to companies set up at his direction by his sister ...

The era of Windows 10 support ended on Oct. 14 of last year. After more than a decade, Microsoft is prioritizing updates for the latest OS, Windows 11, and has thus stopped providing security updates ...

Jiaying This is The English We Speak from BBC Learning English and we’re talking about the phrase ‘another string to your bow’ which describes having an additional skill to use if the first skill ...